Life Science Consulting Group provides results oriented strategies to achieve rapid commercialization, growth and scale up of innovative products and new technologies, primarily in the life sciences. We have 30+ years of expertise in planning and implementing all aspects of commercializing life science products, services and technologies including business plans, financials, product management, production, branding, licensing, global sales and marketing. Expertise includes:• Successfully establishing rapidly growing emerging companies in innovative markets.• Efficiently growing commercial start-ups with tactics, licensing, global sales and distribution.• Creating, managing and implementing business plans, operating budgets and strategies.• Leading and managing funding with equity, debt and grants.• Leading product management and managed product life cycles.• Extensive M&A experience.Successful exits include:• Sirigen (acquired by Becton Dickinson, NYSE: BDX) • Synthetic Genetics (acquired by Epoch Biosciences, NASDAQ: EBIO)• Pharmazyme (acquired by Pharmaceutical Product Development Inc., NASDAQ: PPDI)• Immune Complex Corporation (merged with European vaccine company, EVAX).• American Innovision (acquired by Oncor, NASDAQ: ONCR).